Medtronic, Inc. (MDT) PT Raised to $94 at Barclays
Tweet
Share
E-mail
Get Alerts MDT Hot Sheet
Price: $80.20 +1.17%
Rating Summary:
24 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 11 | New: 23
Rating Summary:
24 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 11 | New: 23
Join SI Premium – FREE
Barclays raised its price target on Medtronic, Inc. (NYSE: MDT) to $94.00 (from $90.00) while maintaining a Overweight rating.
Analyst Matt Taylor remains positive on the equity citing anticipation for improving product cycles and Diabetes recovery which could boost revenue growth in H2 2018 and FY 2019 which in turn could expand the multiple from its current discounted level.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Take-Two Interactive (TTWO) PT Raised to $368 at BofA Securities
- Alaska Air (ALK) PT Raised to $62 at UBS on Updated Q2 Estimates
- Ares Management, L.P. (ARES) PT Raised to $153 at TD Cowen
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
